Navigation Links
Vidiera NsD Nucleic Acid Sample Detection Platform

ProductsVidiera NsD Nucleic Acid Sample Detection Platform
Company Beckman Coulter, Inc.
Item Vidiera NsD Nucleic Acid Sample Detection Platform
Features 
  • Separates and detects DNA fragments
  • Sample to answer in as little as 30 minutes
  • Advanced capillary electrophoresis technology for sensitive, reliable and precise detection
  • Icon-guided, diagnostic-based graphic user interface
  • Pre-defined and user-defined applications
Description The Vidiera NsD Nucleic Sample Detection Platform provides fully automated detection of nucleic acids, post amplification. The new platform for molecular pathology labs separates DNA molecules by capillary electrophoresis (CE), with software features that deliver a high degree of productivity and flexibility. Vidiera NsD has the capacity to run two 96-well plates, and the second plate can be added while the first plate is running. This plate flexibility allows technicians to add rush samples during the run.

Vidiera NsD significantly reduces technician time required to separate nucleic acids for further analysis, running batches of eight samples in as little as 30 minutes. Furthermore, the technician can rapidly change onboard supplies such as separation gels and capillary arrays, which reduces set up time. An extension of Beckman Coulters leadership in CE for research applications, the new Vidiera NsD is offered with accessories to assist high-complexity laboratories in developing assays in the fields of hematology, oncology, cardiovascular health and inherited disorders. The Vidiera NsD platform can be integrated with Beckman Coulters new Vidiera NsP Nucleic Acid Sample Preparation Platform. This instrument is currently only available in the United States.

Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. Vidiera NsP Nucleic Acid Sample Preparation Platform
2. SMS Sample Management System
3. m1000 Automated Sample Preparation
4. StatSampler
5. FISKE® 210 Micro-Sample Osmometer
6. The Advanced® 2020 Multi-Sample Osmometer
7. The Advanced® 3250 Single-Sample Osmometer
8. The Advanced Model 3900 Multi-Sample Osmometer
9. VACUETTE Paediatric Multi-Sample Needle
10. Protein G Samples Pack - .13 OD ; .25 OD; .50 OD per sq. cm
11. Protein A Sample Pack - .13 OD ; .25 OD; .50 OD per sq. cm
...ut patients negative for antinuclear antibodies, w...c diseases such as Systemic lupus erythematosus (L...disease, progressive systemic sclerosis, scleroder...henomenon. They can also be used in conjunction wi...
The PANBIO Inc. Indirect Fluorescence Assay (IFA) for IgG Antinuclear Antibody (ANA) HEp2 is intended for the qualitative and semi-quantitative detection of IgG (Immunoglobulin G) antinuclear antibod
The VerifyNow Clopidogrel Assay measures changes in platelet function in response to patients taking Clopidogrel (Plavix). It uses a specific activator for the P2Y12 pathway, which clopidogrel inhibi
The Wide Angle Twin Mag NP combines the performance of two instruments to deliver unequalled power and versatility into the hands of eye care professionals.
Medicine Products:
(Date:7/25/2008)... The Drug Information Association (...ll host the Critical Path Initiative (CPI) on the ...6; Bethesda, MD) and the Critical Path Transporter... Horsham, PA (PRWEB) July 25,...ation Association (DIA)] and the Food and Drug Adm...
(Date:7/24/2008)...ON-SALEM, N.C. Researchers at Wake Forest Univer...standing clinical belief that the hepatitis C viru...estore itself after HIV patients are treated with ..., Hepatitis C (HCV) infection is more serious in ..., according to the Centers for Disease Control. In...
(Date:7/24/2008)...TH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 I...to report its 2008 second quarter and,year-to-date...econd quarter,and year-to-date financial results o...ing hours., The company will host a conference ca.... Eastern Time) on Tuesday, July 29, 2008. ev3,man...
(Date:7/24/2008)...sts wrote 29% of new orders, followed by GPs and p...DAY, July 24 (HealthDay News) -- Between 2002 and ...epressant drugs increased from 154 million to 170 ...y the U.S. government. , The analysis, by the...tidepressant prescriptions (not including refills)...
Breaking Medicine News(10 mins):Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
...illion women in the United States undergo breast b...umps are benign, //or non-cancerous. But that beni...ne technique is making it easier for women to get ...t cases, benign breast tumors can be left alone. H...
...the final stages of pregnancy seems to increase th...searchers say a diet rich in fish // may boost the...e more fish a woman ate, the less likely she was t...earchers say that low birth weight normally occurs...
...ividuals in lower socioeconomic groups, as measure...ys than those with // higher socioeconomic status,...impact on their health. While those with more educ... not as affected by it. For the study, more than 1...
...h, there is a link between certain types of beddin...recent study show // an association between freque...electric blankets. For the study, synthetic pillow...olyester or Dacron. Quilts of Dacron, polyester or...
Other Medicine News:
(Date:7/23/2008)...ewswire/ -- FluoroPharma Inc., a company developin...sitron Emission Tomography,(PET) market, announced...orine-18 labeled tracer for myocardial perfusion i...lar product to complete Phase I clinical,developme...sess the blood flow in the,heart (myocardial perfu...
(Date:7/23/2008)...23 /- InCode BioPharmaceutics, Inc.,...nced preclinical test,results demonstrating the ut...reatment of the rare chronic blood disorder paroxy...results will be presented at the XXII,Internationa...mber 28,2008., The only treatment currently avai...
(Date:7/23/2008)...ND-Enabling Work with Protein Therapeutics that ... System, CAMBRIDGE, Mass., July 23 /... initiated a corporate growth plan with the,appoin... officer and the,establishment of its headquarters...f Emlen, M.D., a co-founder of the company who rem...
(Date:7/22/2008)...sults from a multi-center 293-patient European, t... Exchange Symbol: CYT, MONTREAL, July 22 /PRNewsw...e global leader in cryotherapy products to treat c...reviously presented from three,European study cent...(R),were published earlier today in the Journal o...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Access Highlighted in Recent BusinessWeek Article 498 1Access Highlighted in Recent BusinessWeek Article 498 2Prescription labels geared toward pharmacies not patients 982 1Prescription labels geared toward pharmacies not patients 982 2Scientists fear rare dolphin driven to extinction by human activities 345 1Scientists fear rare dolphin driven to extinction by human activities 345 2IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 1IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 2